Optibirum and Enamine to expand access to screening compounds, chemical building blocks
Optibrium announced a collaboration with Enamine to provide further database access to users of Optibirum’s software StarDrop.
Optibrium announced a collaboration with Enamine to provide further database access to users of Optibirum’s software StarDrop.
IRBM and Merck have signed a new agreement in the peptide therapeutics area through which the Italian CRO will identify potential peptide leads for a specific Merck target.
The outsourced service providers have signed a new collaboration agreement to provide global pharmaceutical and biotechnology clients access to electrophysiology and ion channel screening.
Neomed-Labs is aiming to double in size and become a global leader in clinical immunology lab services with an investment from Ampersand Capital.
Lonza launched its Capsugel Colorista product, which means it can now produce capsules in 150 colour options.
Sunovion was issued a complete response letter from the US FDA in regards to the company’s new drug application for an ADHD treatment.